FDA delays decision on first drug to prevent HIV infection

   Jun 9, 4:37 pm

London, June 9 (ANI): US health regulators have delayed until mid-September a decision on whether to approve Truvada as the first pill that prevents HIV infection.

Drug maker Gilead Sciences said on Friday that the Food and Drug Administration (FDA) would take an additional three months to review its drug application, after the California Company submitted additional materials to the agency earlier this month.

In May, a panel of experts recommended approval of the daily pill for healthy people at high risk of contracting HIV, the Daily Express reported.

The group's vote is non-binding, but the FDA often follows its advice.

Gilead said that it had submitted updated details on its safety materials for patients and doctors using Truvada.

The FDA typically extends its reviews after receiving such information. (ANI)

Exercise-meditation combo, a weapon against depression Feb 11, 3:20 pm
Washington D.C, Feb 11 (ANI): Fighting depression can really be tough, but if you combine meditation and aerobic exercise together you can beat it, according to a new study.
Full Story
Weight-loss apps that are real deals Feb 11, 3:04 pm
Melbourne, Feb 11 (ANI): According to a recent study, there are only 11 weight-loss apps that are worth bothering with.
Full Story
Weight loss industry dubbed as `Wild West` Feb 11, 2:51 pm
Washington D.C, Feb 11 (ANI): When it comes to shedding those extra kilos, "will" is not the only factor that matters. A new study has found that it is hard for the people with medically serious weight problems to find or have access to proven, reliable programs.
Full Story
A valuable weapon in war against drug-resistant malaria Feb 11, 2:36 pm
Washington D.C, Feb 11 (ANI): A team of researchers has developed a new malaria treatment that offers hope in the global race to beat the parasite's deadly new resistance.
Full Story
Comments